All News

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

I underwent cancer treatments during my lunch breaks at work. Looking back, I wish I took some time off.

The OnPrime trial will investigate if adding Olvi-Vec, a modified virus, to chemotherapy and Avastin will improve outcomes for pretreated platinum-resistant or refractory ovarian cancer.

Former Cincinnati Reds catcher, and MLB Hall of Famer, Johnny Bench is using his stature as a public figure to advocate for skin cancer prevention and detection.

I’m surviving cancer while getting older, too — that means I can no longer do some of the things I did when I was younger.

The addition of Bavencio to an Inlyta regimen may help stabilize disease in some patients with thymic carcinoma, but one expert stressed that checkpoint inhibitors are “problematic” for patients diagnosed with thymoma, a type of rare cancer.

While I've been deemed no evidence of disease, I'll continue to support others in my cancer wolfpack.

After I held my hand as my mom died, I wondered who would hold mine as I went through cancer.

CURE®’s Lung Cancer Heroes® Award Program honors and gives thanks to those heroes who have positively affected the lives of patients with lung cancer.

Seven years after completing breast cancer treatment, Angelia Carpenter was shocked to discover she had angiosarcoma, a rare cancer that may have been associated with her breast cancer treatment.

When talking about cancer, it’s OK to use profanities sometimes.

From NFL Hall of Famer Shannon Sharpe and Monty Python member sharing their cancer diagnoses to “Good Morning America” promoting Be The Match, here’s what’s happening in the cancer space this week.

A decision to rename myeloproliferative neoplasms led to a plethora of developments in a space where there was once little interest.

Maintenance therapy helps deter undetectable cancer that may exist after initial treatment.

Patients with blood cancer who have higher levels of neurofilament light chains — which indicate brain injury — were found to be more likely to develop neurotoxicity after CAR-T cell therapy, according to recent research.

I used to love October, but after being diagnosed with cancer on Oct. 12 — twice — I dread the month.

While I’m usually a private person, it’s important to me to share my three bouts with cancer so that others will learn their bodies and their family history.

The Food and Drug Administration approved Retevmo for the treatment of patients with advanced or metastatic non-small cell lung cancer with a rearranged RET gene fusion.

Cancer made me more empathetic, as well as an advocate for the HPV vaccine.

Three out of four women with lung cancer reported experiencing moderate to severe sexual dysfunction, a survey shows.

It’s good that celebrities with cancer raise awareness about the disease, but I think that they can do more.

Melanoma of the skin has been shown to be greatly associated with exposure to sunlight, whereas uveal melanoma — commonly known as cancer of the eye — is not.

The Food and Drug Administration approved Pedmark for the prevention of chemotherapy-induced hearing loss in pediatric patients with localized, nonmetastatic solid cancers.

Although patients treated with the combination did not have significant improvements in survival, telaglenastat and Cabometyx did not increase the rate of side effects in patients.

Pets may be like family to some individuals but caring for them during illnesses such as cancer may force some to make a difficult decision.

When my husband was diagnosed with prostate cancer in his mid 40s, we opted for a more aggressive treatment strategy, which led him being cancer-free and able to enjoy a healthy sex life.

Years ago, the goal of head and neck cancer treatment was strictly focused on a cure. Now, there has been a slight change in approach to improve survival rates while preserving quality of life.

The Food and Drug Administration granted a priority review for Tukysa plus Herceptin for patients with pretreated, metastatic colon cancer.